Literature DB >> 3967099

Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosynthetic (recombinant) alpha-2-interferon.

A D Jacobs, F Naiem, R E Champlin, D W Golde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3967099     DOI： 10.1007/bf00319768

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  1 in total

1.  Alpha interferon for induction of remission in hairy-cell leukemia.

Authors:  J R Quesada; J Reuben; J T Manning; E M Hersh; J U Gutterman
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245
  1 in total
  3 in total

1.  Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

Authors:  F Porzsolt
Journal:  Blut       Date:  1986-05

2.  Long-lasting remission of hairy cell leukemia after eight weeks' therapy with low-dose alpha-(leucocyte-)interferon.

Authors:  U Dührsen; P Meusers; E Gries; G Brittinger
Journal:  Blut       Date:  1985-10

Review 3.  Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies.

Authors:  K Teelmann; C Hohbach; H Lehmann
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.